Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × Rosiglitazone × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Gastrointestinal 1 Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Sezary Syndrome 1 Mycosis Fungoides 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Carcinoma, Hepatocellular 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 3 Nivolumab 2 obinutuzumab 1 naptumomab estafenatox 1 durvalumab 1 Rosiglitazone 1 Metformin 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04114136 2025-02-10

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

University of Pittsburgh

Phase 2 Recruiting

DermatologicGastrointestinalHead & Neck

Adenocarcinoma Of Esophagus, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hepatocellular, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡